Lupin gets USFDA nod for generic medication
The company has received approval from the US Food and Drug Administration to market Fesoterodine Fumarate extended-release tablets in strengths of 4 mg and 8 mg, the Mumbai-based drug maker said in a regulatory filing
Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.
